PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
TI  - Isavuconazole Effective in UncCAs and HMs
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 14--16
VI  - 14
IP  - 28
4099  - http://mdc.sagepub.com/content/14/28/14.short
4100  - http://mdc.sagepub.com/content/14/28/14.full
AB  - Patients with invasive fungal disease and comorbid conditions such as hematologic malignancy and uncontrolled malignancy were successfully treated with the novel triazole antifungal agent isavuconazole, regardless of minimum inhibitory concentrations required by baseline Aspergillus spp isolates. This article presents data according to type of malignancy from the Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis trial [SECURE; NCT00412893].